Matsuyama K, Sen A C, Perrin J H
J Pharm Pharmacol. 1987 Mar;39(3):190-5. doi: 10.1111/j.2042-7158.1987.tb06247.x.
The binding of the non-steroidal anti-inflammatory drug, tolmetin (1-methyl-5-p-toluoylpyrrole-2-acetic acid) to human serum albumin (HSA) has been shown by circular dichroism, fluorescence and equilibrium dialysis to be dependent on the N-B conformational change of the albumin. The influence of calcium and chloride ions on the interaction was also investigated using the same techniques. Experiments suggested that calcium ions increased the binding constant of tolmetin to HSA whereas chloride ions decreased it. The displacement study showed that tolmetin caused a significant increase in the affinity of diazepam to HSA whereas it decreased the binding of warfarin to HSA. Tolmetin seems to cause an allosteric change in the diazepam binding site in spite of it sharing a primary site with warfarin.
通过圆二色性、荧光和平衡透析法已证明,非甾体抗炎药托美丁(1-甲基-5-对甲苯甲酰基吡咯-2-乙酸)与人血清白蛋白(HSA)的结合取决于白蛋白的N-B构象变化。还使用相同技术研究了钙离子和氯离子对这种相互作用的影响。实验表明,钙离子增加了托美丁与HSA的结合常数,而氯离子则降低了该常数。置换研究表明,托美丁使地西泮与HSA的亲和力显著增加,而降低了华法林与HSA的结合。尽管托美丁与华法林共享一个主要结合位点,但它似乎会引起地西泮结合位点的变构变化。